The grant was awarded by the National Eye Institute and the National Institutes of Health, according to a July 8 news release from Wayne State University. Dr. Kumar’s will research ferroptosis, a type of regulated cell death. Ferroptosis damages the retina during bacterial endophthalmitis, a severe type of intraocular infection that can occur after surgery or trauma.
The research will incorporate microbiology, immunology, cell biology and nanotechnology to increase understanding of ferroptosis and develop new clinical therapies for bacterial endophthalmitis.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.